Vivo Capital as of Sept. 30, 2017
Portfolio Holdings for Vivo Capital
Vivo Capital holds 29 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biohaven Pharmaceutical Holding | 14.9 | $74M | 2.0M | 37.38 | |
| Aclaris Therapeutics (ACRS) | 14.9 | $74M | 2.9M | 25.81 | |
| Ascendis Pharma A S (ASND) | 12.9 | $64M | 1.8M | 36.25 | |
| Nabriva Therapeutics | 6.7 | $33M | 4.1M | 8.19 | |
| Kala Pharmaceuticals | 5.3 | $27M | 1.2M | 22.84 | |
| Verona Pharma Plc ads (VRNA) | 4.6 | $23M | 1.5M | 15.35 | |
| Strongbridge Bioph shs usd | 4.1 | $20M | 3.0M | 6.90 | |
| Selecta Biosciences | 4.1 | $20M | 1.1M | 18.25 | |
| Codexis (CDXS) | 4.1 | $20M | 3.1M | 6.65 | |
| Eiger Biopharmaceuticals | 4.0 | $20M | 1.8M | 11.00 | |
| Aimmune Therapeutics | 3.9 | $19M | 777k | 24.79 | |
| Advanced Accelerat spon ads each rep 2 ord | 3.4 | $17M | 249k | 67.62 | |
| Kadmon Hldgs | 2.3 | $11M | 3.3M | 3.35 | |
| Amyris | 1.8 | $9.0M | 2.8M | 3.20 | |
| Zai Lab (ZLAB) | 1.8 | $8.8M | 325k | 27.00 | |
| Aurinia Pharmaceuticals (AUPH) | 1.5 | $7.6M | 1.2M | 6.27 | |
| Soleno Therapeutics | 1.5 | $7.6M | 15M | 0.52 | |
| Agile Therapeutics | 1.4 | $6.8M | 1.5M | 4.46 | |
| Regenxbio Inc equity us cm (RGNX) | 1.1 | $5.4M | 164k | 32.95 | |
| Foamix Pharmaceuticals | 1.0 | $4.7M | 855k | 5.55 | |
| Trevena | 0.9 | $4.4M | 1.7M | 2.55 | |
| Biopharmx | 0.8 | $4.1M | 14M | 0.29 | |
| Sierra Oncology | 0.8 | $3.8M | 2.4M | 1.55 | |
| Crispr Therapeutics (CRSP) | 0.5 | $2.7M | 149k | 17.87 | |
| Revance Therapeutics | 0.4 | $2.1M | 77k | 27.55 | |
| Akari Therapeutics | 0.4 | $2.1M | 346k | 6.14 | |
| Kalvista Pharmaceuticals (KALV) | 0.4 | $2.0M | 300k | 6.73 | |
| Sunesis Pharmaceuticals Inc Ne | 0.2 | $970k | 500k | 1.94 | |
| Soleno Therapeutics Inc Wt S E w | 0.0 | $113k | 944k | 0.12 |
